Literature DB >> 10525391

Endometrial adenocarcinoma in pregnancy.

A Ayhan1, S Gunalp, C Karaer, A Gokoz, U Oz.   

Abstract

OBJECTIVE: The coexistence of endometrial adenocarcinoma and pregnancy is rare. Most cases are discovered in the first trimester due to irregular bleeding or spontaneous abortion. CASE: A 44-year-old woman, gravida 3, para 2, was admitted due to abnormal vaginal bleeding. After complete history, physical examination, and laboratory evaluation, she was diagnosed with spontaneous abortion and underwent a suction curettage. Pathological examination of the tissue included chorionic villi and an area of atypical hyperplasia and endometrial cancer.
CONCLUSION: Recent association between first-trimester spontaneous abortions and subsequent endometrial cancer makes these rare cases of concurrent endometrial cancer and first trimester of pregnancy attractive in that they may disclose insights into the pathophysiology of hormone-dependent cancers. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10525391     DOI: 10.1006/gyno.1999.5576

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Endometrial adenocarcinoma in spontaneous abortion: two cases and review of the literature.

Authors:  Feng Zhou; Zhida Qian; Yinghua Li; Jiale Qin; Lili Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Tubal pregnancy associated with endometrial carcinoma after in vitro fertilization attempts.

Authors:  Yesim Bayoglu Tekin; Emine Seda Guvendag Guven; Ibrahim Sehitoglu; Suleyman Guven
Journal:  Case Rep Obstet Gynecol       Date:  2014-12-28

Review 3.  Endometrial carcinoma in a gravid uterus: a case report and literature review.

Authors:  Mayu Shiomi; Shinya Matsuzaki; Eiji Kobayashi; Takeya Hara; Satoshi Nakagawa; Tsuyoshi Takiuchi; Kazuya Mimura; Yutaka Ueda; Takuji Tomimatsu; Tadashi Kimura
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-20       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.